Search Tag: obesity
2025 14 Nov
The global prevalence of high blood pressure among children and adolescents nearly doubled between 2000 and 2020, according to a new meta-analysis published in The Lancet Child & Adolescent Health . In 2000, an estimated 3.2% of children had hypertension. By 2020, that figure had risen to more than 6.2% among those under 19, affecting roughly...Read more
2025 09 Oct
A new report from researchers at the Pennington Biomedical Research Center highlights the growing promise of precision medicine to reshape how obesity is prevented, diagnosed, and treated, while underscoring critical evidence gaps that must still be addressed. Published in Obesity , the paper, “Precision Prevention, Diagnostics and Treatment...Read more
2025 11 Sep
Adults over 65 who lose or fluctuate more than 5% of their body weight may face faster cognitive decline, according to new research from Penn State’s Department of Nutritional Sciences. The findings are published in Obesity . Study researchers looked at 11 years of data on weight, body mass index (BMI), and waist circumference. Across three...Read more
2025 23 Jul
Popular GLP-1 drugs can help many people shed significant weight, but they may fall short in delivering a key benefit essential for long-term health: improving heart and lung fitness, University of Virginia researchers caution in a new paper. The team emphasises that weight loss from GLP-1 drugs offers clear health benefits for people with obesity,...Read more
2025 10 Jul
A new cross-sectional and longitudinal analysis evaluated how the European Association for the Study of Obesity’s (EASO) recently introduced framework reclassifies obesity levels and examined mortality risk among those newly identified as having obesity under this framework. The study, published in Annals of Internal Medicine , found that...Read more
2025 13 Jun
The rising prevalence of obesity represents one of the most pressing public health and economic challenges of the modern era. With nearly 900 million adults worldwide living with obesity and significant associated risks for at least 20 diseases, the burden extends beyond individual health to entire societies. This crisis could result in an estimated...Read more
2025 13 May
A new head-to-head clinical trial comparing tirzepatide and semaglutide for weight loss in people with obesity but without diabetes demonstrates that tirzepatide led to significantly greater weight reduction. Over a 72-week period, participants receiving tirzepatide achieved an average weight loss of 20.2%, compared to 13.7% with semaglutide—a difference...Read more
2025 30 Apr
Over the past 20 years, the average rate of obesity among U.S. adults has increased by nearly 30%. However, the prevalence of the most extreme forms of obesity—defined as having a body mass index (BMI) of 60 kg/m² or higher—has risen by a staggering 210%. Scientists from Pennington Biomedical Research Center analysed national health data from...Read more
2025 10 Mar
Obesity has become a pressing public health crisis, with rates surging over the past few decades. The condition, defined by a body mass index (BMI) of 30 or higher, is linked to over 250 health complications, including diabetes, heart disease and certain cancers. Additionally, obesity is associated with mental health disorders such as anxiety...Read more
2025 10 Mar
Obesity has become a pressing public health crisis, with rates surging over the past few decades. The condition, defined by a body mass index (BMI) of 30 or higher, is linked to over 250 health complications, including diabetes, heart disease and certain cancers. Additionally, obesity is associated with mental health disorders such as anxiety...Read more
2025 24 Feb
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) has become a global health challenge, closely linked to a variety of serious comorbidities, including cardiovascular disease, type 2 diabetes and liver-related complications. As the prevalence of MASLD continues to rise, particularly in populations affected by obesity and insulin resistance,...Read more
2025 28 Jan
A recent study by the Boston University School of Public Health (BUSPH) highlights significant barriers faced by individuals with obesity in accessing weight-loss medications like semaglutide, particularly within a healthcare system that has historically deprioritised obesity treatment. Initially developed to manage diabetes, glucagon-like...Read more
2025 15 Jan
A global Commission published in The Lancet Diabetes & Endocrinology , endorsed by over 75 medical organisations worldwide, proposes a groundbreaking approach to diagnosing obesity. This model integrates measures of excess body fat with objective signs and symptoms of individual ill health, moving beyond the traditional reliance on body mass index...Read more
2024 27 Nov
A recent study confirms that metabolic and bariatric surgery is a largely safe and effective option for individuals with severe obesity, including those with a body mass index (BMI) of 70 kg/m² or higher. The findings are published in Obesity Surgery: The Journal of Metabolic Surgery and Allied Care. The research analysed data from 84 patients...Read more
2024 19 Nov
Over the past three decades, obesity rates across the United States have surged dramatically, with prevalence among adults (25+ years) and older adolescents (15–24 years) more than doubling since 1990. By 2021, over 208 million Americans were living with overweight or obesity—a figure projected to escalate without significant reforms, according to...Read more
2024 29 Oct
According to a study led by the Yale School of Public Health and the University of Florida, expanding access to new, highly effective weight-loss medications could save over 40,000 lives annually in the U.S. The research highlights the urgency of removing barriers that prevent people from accessing effective obesity treatments, a crucial step toward...Read more
2024 29 Oct
Obesity is a chronic, complex, and relapsing disease characterised by excessive fat accumulation that poses significant health risks. The World Health Organization (WHO) reports that obesity contributes to the deaths of at least 2.8 million people annually. Since 1990, adult obesity rates have more than doubled, and in 2022, an estimated 890 million...Read more
2024 07 Oct
People struggling with obesity face numerous social and health challenges, but a new study suggests these difficulties may be less severe in areas where obesity is more common. The study is published in Psychological Science. The researchers analysed data from over 3.4 million people in the U.S. and the U.K. They found that the negative medical...Read more
2024 23 Sep
Researchers from the University of Copenhagen have identified lipid biomarkers in children and teens with obesity that indicate an increased risk of developing type 2 diabetes, heart disease, and liver conditions later in life. A one-year lifestyle intervention was found to reduce these lipid biomarkers, underscoring the importance of early intervention...Read more
2024 17 Sep
A new study has identified key factors that influence long-term weight loss in patients with obesity who were prescribed injectable semaglutide or liraglutide for the treatment of type 2 diabetes or obesity. The findings are published in JAMA Network Open. In patients with obesity treated with semaglutide or liraglutide, study researchers observed...Read more
2024 26 Aug
According to a new study, the anti-obesity drug semaglutide may help prevent heart attacks and other major cardiac events in overweight individuals with cardiovascular disease, whether or not they also have heart failure. The study is published in The Lancet. This research builds on previous findings, which showed that weekly injections of semaglutide...Read more
2024 26 Aug
A new study from the University of Georgia reveals that Type 2 diabetes surged by nearly 20% between 2012 and 2022. The research shows an increase in diabetes across all sociodemographic groups, with non-Hispanic Black individuals being particularly affected—nearly 16% of Black participants reported a Type 2 diabetes diagnosis. The study also...Read more
2024 24 Jul
Semaglutide emerged as the most frequently prescribed GLP-1 receptor agonist (GLP-1RA) in 2023 by a significant margin. A nationwide study revealed a substantial rise in new GLP-1RA prescriptions over the past decade, especially since 2020. While semaglutide dominated prescriptions in 2023, the study also noted a shift in the patient...Read more
2024 10 Jul
The approach to diagnosing and managing obesity must go beyond body mass index (BMI), which often excludes many individuals who could benefit from treatment. The European Association for the Study of Obesity (EASO) has launched a new framework for diagnosing, staging, and managing obesity in adults. This framework aims to modernise obesity diagnosis...Read more
2024 10 Jul
Since 1990, the prevalence of obesity among children and adolescents (as measured by body mass index, BMI) has increased fourfold, while obesity rates among adults have more than doubled. This trend in the obesity epidemic is expected to elevate the risk of BMI-associated diseases, particularly cardiovascular diseases and type 2 diabetes. ...Read more
2024 11 Jun
New research reveals that moderate to vigorous physical activity in the evening is most beneficial for lowering daily blood sugar levels in sedentary adults with overweight and obesity. The findings are published in Obesity. It is well established that moderate to vigorous physical activity enhances glucose homeostasis in overweight and...Read more
2024 02 Jun
People under 50 face a higher risk of heart attack or stroke if they’ve lived with obesity for 10 years, according to research presented at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Massachusetts. People with excess weight at any point in time have a greater risk of heart attacks and strokes. However, whether the duration...Read more
2024 22 May
Obesity prevalence has steadily risen, affecting over 40% of U.S. adults aged 20 and older. Scientific advances have illuminated the multifaceted causes of obesity, including sociological and physiological factors. Treatment strategies now encompass lifestyle modifications, medications, and bariatric surgery, each posing unique implementation challenges....Read more
2024 05 Mar
A global analysis published in The Lancet reveals that the number of people worldwide living with obesity has surpassed one billion. Over the years from 1990 to 2022, obesity rates among children and adolescents increased fourfold, while rates among adults more than doubled. Simultaneously, rates of underweight decreased across all age groups,...Read more
2023 05 Sep
Novo Nordisk, the Danish pharmaceutical giant behind the weight-loss medication Wegovy (active ingredient - semaglutide), has become Europe's most valuable company, dethroning the French luxury conglomerate LVMH. Following the successful launch of Wegovy in the U.K., the company's shares saw a significant uptick in value. As trading closed...Read more